Behcet's disease: Current aspects in the etiopathogenesis;Behçet hastaliǧi: Etyopatogenezde güncel bilgiler

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 43, Issue SUPPL. 2, 2009, Pages 32-38

  Akman, Ayşe ^a   Alpsoy, Erkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Aetiopathogenesis; Behcet's disease; Genetic factors; Immunologic system; Infectious agents

Indexed keywords

BEHCET DISEASE; HUMAN; PATHOGENESIS; REVIEW;

EID: 79551478536     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Zierhut M, Mizuki N, Ohno S, Inoko H, Gül A, Onoé K, Isogai E: Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003;60:1903-22.
2. Alpsoy E: Behçet Hastaliǧinin Deri ve Mukoza Belirtileri: Deri Hastali klari ve Frengi Arşivi 2003;37:92-9.
3. Alpsoy E, Akman A: "Behçet Hastaliǧi; Etyopatogenezde Yeni Kavramlar", Türkiye Klinikleri J Int Med Sci 2007;3:8-14.
4. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M: Close assosiation of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982;100:1455-8.
5. Arayssi T, Hamdan A: New insights into the pathogenesis and therapy of Behçet's disease Curr Opin Pharmacol. 2004;4:183-8.
6. Mizuki N, Inoko H, Ando H, Nakamura S, Kashiwase K, Akaza T, Fujino Y, Masuda K, Takiguchi M, Ohno S: Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol. 1993;116:406-9.
7. Koumantaki Y, Stavropoulos C, Spyropoulou M, Messini H, Papademetropoulos M, Giziaki E, Marcomichelakis N, Palimeris G, Kaklamanis P, Kaklamani E: HLA-B51 in Greek patients with Behçet's disease. Hum Immunol 1998:59:250-5. (Pubitemid 28176424)
8. Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H: HLA-B51 allele analysis by the PCR-SBT method and a strong association of HLA-B5101 with Japanese patients with Behçet's disease Tissue Antigens. 2001;58:181-4.
9. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T: Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38:426-33.
10. Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001;44:239-40.
11. Alpsoy E, Yilmaz E, Savas A, Coskun M, Yegin O: HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients. The Journal of Dermatology 1998;25:158-62. (Pubitemid 28169528)
12. Gül A, Hajeer AH, Worthington J, Ollier WE, Silman AJ: Linkage Mapping of a Novel Susceptibility Locus for Behçet's Disease to Chromosome 6p22-23. Artritis Rheum 2001;44:2693-6. (Pubitemid 33049347)
13. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES: HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Tissue Antigens. 2007;69:139-44. (Pubitemid 46174868)
14. Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP: Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003;48:807-13.
15. Akman A, Sallakci N, Coşkun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O: TNF-alfa gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. British Journal of Dermatology 2006;155:350-6. (Pubitemid 44050569)
16. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura S, Bahram S, Inoko H: Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 1997;94:1298-303. (Pubitemid 27087845)
17. Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Goto K, Nakamura S, Bahram S, Ohno S, Inoko H: Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease. Arthritis Rheum 1999;42:1961-6. (Pubitemid 30257763)
18. Wallace GR, Verity DH, Delamaine LJ, Ohno S, Inoko H, Ota M, Mizuki N, Yabuki K, Kondiatis E, Stephens HA, Madanat W, Kanawati CA, Stanford MR, Vaughan RW: MIC-A allele profiles and HLA class I associations in Behcet's disease. Immunogenetics 1999;49:613-7. (Pubitemid 29278447)
19. Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O: Spesific interleukin-1 gene polymorphisms in Turkish patients with Behçet' disease. Experimental Dermatology 2005:14:124-9. (Pubitemid 40277579)
20. Akman A, Ekinci NC, Kacaroglu H, Yavuzer U, Alpsoy E, Yegin O: Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behçet's disease. Arch Dermatol Res 2008;300:19-26. (Pubitemid 350231461)
21. Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A: Association of specific interleukin 1 gene clusterpolymorphisms with increased susceptibility for Behçet's disease. Rheumatology 2003;42:860-4. (Pubitemid 37220935)
22. Duymaz-Tozkir J, Yilmaz V, Uyar FA, Hajeer AH, Saruhan-Direskeneli G, Gul A: Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease. J Rheumatol. 2005;32:93-7. (Pubitemid 40092598)
23. Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F: Role of IL-12B promoter polymorphism in Adamantiades-Behçet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. J Invest Dermatol. 2006;126:1444-7.
24. Sallakci N, Bacanli A, Coskun M, Yavuzer U, Alpsoy E, Yegin O: CTLA-4 gene 49 A/G polymorphism in Turkish patients with Behçet's disease. Clin Exp Dermatol. 2005;30:546-50. (Pubitemid 41076025)
25. Nam EJ, Han SW. Kim SU, Cho JH, Sa KH, Lee WK, Park JY, Kang YM: Association of Vasculer Endotelial Growth Factor Gene Polymorphisms With Behçet Disease in a Korean Population. Human Immunol. 2005;66:1068-73.
26. Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L: Intercelluler adhesion molecule- 1 gene polymorphisms in Behçet's Disease. J Rheumatol 2001;28:1283-7. (Pubitemid 32510499)
27. Salvarani C, Boiardi L, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni P: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 2002;29:535-40. (Pubitemid 34202824)
28. Yalcin B, Atakan N, Alli N: The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study. Clin Exp Dermatol 2008;33:629-33.
29. Imirzalioglu N, Dursun A, Tastan B, Soysal Y, Yakicier MC: MEFV gene is a probable susceptibility gene for Behcet's disease. Scand J Rheumatol 2005;34:56-8. (Pubitemid 40445060)
30. Atagunduz P, Ergun T, Direskeneli H: MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003;21:35-7.
31. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH: Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study. Arthritis Res Ther 2009;11:66.
32. Eglin RP, Lehner T, Subak-Sharpe JH: Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982;2:1356-61. (Pubitemid 13254787)
33. Lehner T: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int Rev Immunol 1997;14:21-32.
34. Studd M, McCance DJ, Lehner T: Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 1991;34:39-43.
35. Lee ES, Lee S, Bang D, Sohn S: Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet's disease. In: Melasma Hamza, ed. Proceedings of the 7th International Conference on Behcet's Disease. Tunis, Tunisia: Pub Adhona 1997;71-4.
36. Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R, Adim SB, Goral G, Dilek K, Tunali S: Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clin Exp Dermatol 2007;32:186-90. (Pubitemid 46233026)
37. Kaneko F, Takahashi Y, Muramatsu Y, Miura Y: Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease. Br J Dermatol 1985;113:303-12. (Pubitemid 15246605)
38. Isogai E, Ohno S, Takehashi K: Close association of Streptococcus sangius uncommon serotypes with Behçet's disease. Bifidobact Microflora 1990;9:27-41.
39. Mizushima Y, Matsuda T, Hoshi K, Ohno S: Induction of Behçet's disease symptoms following dental treatment and streptococcal antigen skin test. J Rheumatol 1988;61;1029-30.
40. Alpsoy E, Akman A: Behçet's disease: an algorithmic approach to its treatment. Arch Dermatol Res 2009;301:693-702.
41. Alpsoy E. Behçet's disease: treatment of mucocutaneous lesions. Clin Exp Rheumatol 2005;23:532-9. (Pubitemid 41447628)
42. Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, Direskeneli H: Oral health is impaired in Behcet's disease and is associated with disease severity. Rheumatology (Oxford). 2004;43:1028-33.
43. Akman A, Kacaroglu H, Donmez L, Bacanli A, Alpsoy E: Relationship between periodontal findings and Behcet's disease: a controlled study. J Clin Periodontol. 2007;34:485-91.
44. Celenligil-Nazliel H, Kansu E, Ebersole J: Periodontal findings and systemic antibody responses to oral microorganisms in Behcet's disease. J Periodontol 1999;70:1449-56.
45. Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, Yegin O: Relationship between periodontal findings and the TNFalpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease. J Eur Acad Dermatol Venereol. 2008;22:950-7.
46. Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H, Direskeneli H, Gunaydin Y, Dinc A: The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study. J Oral Pathol Med. 2009;38:410-5.
47. Lehner T, Lavery E, Smith R, van der Zee R, Mizushima Y, Shinnick T: Association between the 65-kilodalton heat shock protein, streptococcus sanguis, and the corresponding antibodies in Behçet's disease. Infect Immun 1991;59:1434-41.
48. Direskeneli H, Hasan A, Shinnick T, Mizushima R, van der Zee R, Fortune F, Stanford MR, Lehner T: Recognition of B-cell epitopes of the 65 kDa HSP in Behcet's disease. Scand J Immunol 1994;43:464-71.
49. Hamzaoui K, Ayed K, Slim A, Hamza M, Touraine J: Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patient's with Behçet's disease. Clin Exp Immunol 1990:79:28-34.
50. Lew W, Lee SH, Bang D, Lee S, Kim JC, Chung TH: Serum tumor necrosis factor, interleukin-1-beta and interleukin-6 levels in Behçet's disease. Ann Dermatol 1993:5:69-73.
51. Turan B, Gallati H, Erdi H, Gurler A, Michel BA, Villiger PM: Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechcet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol. 1997;24:128-32.
52. Alpsoy E, Cayirli C, Er H, Yilmaz E: The levels of plasma interleukin- 2 and soluble interleukin-2r in Behçet's disease; A marker of disease activity. The Journal of Dermatology 1998;25:513-6.
53. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanç M, Capo C: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6; IL-8 and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993:20:1544-9.
54. Itoh R, Takenaka T, Okitsu-Negishi S, Matsushima K, Mizogouchi M: Interleukin-8 in Behçet's disease. J Dermatol 1994:21:397-404.
55. Sayinalp N, Özcebe OI, Özdemir O, Haznedaroglu IC, Dündar S, Kirazli S: Cytokines in Behçet's disease. J Rheumatol 1996:23:321-2.
56. Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K: Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand J Rheumatol. 2002;31:205-10. (Pubitemid 34971876)
57. Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis ChC: Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 2003;206:225-32.
58. Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R: Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996;55:128-33. (Pubitemid 26050122)
59. Sakane T: New perspective in Behçet's disease. Int Rev Immunol 1997;14:89-96.
60. Rizzi R, Bruno S, Dammacco R: Behçet's disease: An immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997;27:225-32. (Pubitemid 127509863)
61. Hirohata S, Oka H, Mizushima Y: Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease. Cell Immunol 1992;140:410-9.
62. Nagafuchi H, Takeno M, Yoshikawa H, Kurokawa MS, Nara K, Takada E, Masuda C, Mizoguchi M, Suzuki N: Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Clin Exp Immunol. 2005;139:363-70.
63. Li B, Yang P, Zhou H, Zhang Z, Xie C, Lin X, Huang X, Kijlstra A: Tbet expression is upregulated in active Behcet's disease. Br J Ophthalmol. 2003;87:1264-7. (Pubitemid 37193919)
64. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H: Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheumatism 2004;50:2291-5. (Pubitemid 38924408)
65. Fortune F, Walker J, Lehner T: The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet's syndrome. Clin Exp Immunol 1990;82:326-32.
66. Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M: Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behcet's disease. J Rheumatol 1994;21:2301-6.
67. Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, van der Zee R, Stanford MR, Sanderson J, Lehner T: Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet 1996;347:789-94. (Pubitemid 126512033)
68. Lehner T: State of art in Behçet Disease. 8th International Conference on Behçet's disease 1998.
69. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR: Autoimmune inflammation from the Th17 perspective. Autoimmun Rev. 2007;6:169-75.
70. Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A: Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058-64.
71. Sayin N, Alpsoy E, Akman A, Büyükkara Yilmaz S, Yegin O: The role of IL-17 in activity of Behcet's disease. Journal of Investigative Dermatology 2009;129(Suppl 2):S99-S99.
72. Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T: Monocyte activity in Behçet's disease. Br J Rheumatol 1996;35:424-9.
73. Nakamura S, Sugita M, Tanaka S, Ohno S: Enhanced production of in vitro tumor necrosis factor-alpha from monocytes in Behcet's disease. Nippon Ganka Gakkai Zasshi 1992;96:1282-5.
74. Treudler R, Zouboulis CC, Buttner P, Detmar M, Orfanos CE: Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades- Behcet disease. Arch Dermatol 1996;132:1323-9.
75. Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M: Pathological haemostasis and "prothrombotic state" in Behcet's disease. Thromb Res 2002;105:125-33.
76. Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O: Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease. Clin Exp Dermatol 2006;31:699-701. (Pubitemid 44086803)
77. Direskeneli H, Saruhan-Direskeneli G: The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol 2003;21:44-8.
78. Mertens D, Koetter I, Guenaydin I, Fresko I, Yazici H, Mueller C: Expression of •-defensins HNP 1-3 in Behcet's disease: Effector molecules of spontaneous and pathergy induced (papulo)pustular lesions?. Clin Exp Rheumatol 2004;34:93.
79. Mumcu G, Inanc N, Aydin SZ, Ergun T, Direskeneli H: Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behçet's disease. Clin Exp Rheumatol 2009;27:32-6.
80. Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, Nussenblatt RB: Alpha tropomyosin as a self-antigen in patients with Behcet's disease. Clin Exp Immunol. 2005;140:368-75.
81. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D: Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003;48:2025-35. (Pubitemid 36828698)
82. Lu Y, Ye P, Chen SL, Tan EM, Chan EK. Identification of kinectin as a novel Behcet's disease autoantigen. Arthritis Res Ther 2005;7:1133-9.